HomeHOWL • NASDAQ
Werewolf Therapeutics Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.68M | -3.60% |
Net income | -18.09M | -11.71% |
Net profit margin | — | — |
Earnings per share | -0.40 | -2.56% |
EBITDA | -17.57M | -5.19% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 92.04M | -33.87% |
Total assets | 107.24M | -39.62% |
Total liabilities | 49.93M | -16.80% |
Total equity | 57.31M | — |
Shares outstanding | 44.87M | — |
Price to book | 0.93 | — |
Return on assets | -38.42% | — |
Return on capital | -43.92% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -18.09M | -11.71% |
Cash from operations | -18.95M | -23.87% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -18.95M | -490.60% |
Free cash flow | -13.31M | -26.12% |
Previous close
$1.19
Day range
$1.18 - $1.23
Year range
$0.60 - $4.18
Market cap
54.07M USD
Avg Volume
617.08K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2017
Headquarters
Website
Employees
46
